ClinicalTrials.Veeva

Menu

C-Reactive Protein as a Predictor for Airway Hyper-Responsiveness

R

Rambam Health Care Campus

Status

Completed

Conditions

Asthma

Treatments

Other: blood sampling

Study type

Observational

Funder types

Other

Identifiers

NCT01002144
CRPAHR - CTIL

Details and patient eligibility

About

Background: Increased serum high sensitivity C-reactive protein (hs-CRP) has been associated with airway inflammation in asthma and may serve as a surrogate marker for the presence of airway hyper-responsiveness (AHR) in this set-up. This study was designed to evaluate the predictive value of hs-CRP for AHR assessed by metacholine challenge test (MCT), in adults with suspected Asthma.

Enrollment

88 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • subjects that were referred to Metacholine challenge test

Exclusion criteria

  • age < 18

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems